Place
Oxford: startups, funding and events
Capital tracked€332,552,000
Rounds15
Startups12
€332.6M
Capital tracked
15
Disclosed rounds
€88.9M
Biggest round
12
Startups tracked
Oxford, in numbers
15 rounds on record · 15 with a disclosed amount
Rounds by stage
Seed 30%
Pre-seed 20%
Series D+ 10%
Series C 10%
Growth 10%
Capital by year
Share of rounds
Source: Sesamers round tracker · full data desk →
Largest rounds tracked
Disclosed rounds only · EUR-converted at desk rates
| Company | Round | Sector | Lead | Amount |
|---|---|---|---|---|
| Oxa United Kingdom | Series D+ | AI | UK National Wealth Fund | €88.9M |
| Oxa United Kingdom | Growth | AI | - | €87.3M |
| Wild Bioscience United Kingdom | Undisclosed | Agritech | - | €51M |
| Alloyed United Kingdom | Undisclosed | Additive Manufacturing | - | £37M |
| Salience Labs United Kingdom | Series A | Industry | - | $30M |
| Scripta Therapeutics United Kingdom | Seed | AI | Oxford Science Enterprises, Apollo Health Ventures | €10.3M |
Startups in Oxford
From the directory
AL
Alloyed
Additive Manufacturing
Metal additive manufacturing and alloy design for aerospace and electronics parts
view →
SL
Salience Labs
Industry · Series A
Photonic switching and optical interconnect chips for AI datacentres
Series A · $30,000,000
view →
DE
Dexory
Industrial Robotics · Series C
Autonomous scanning robots and digital twin software for warehouse inventory
Series C · €9,800,000
view →
Who invests here
Funds with a verified round in this hub · most active first
Oxford Science Enterprises
Pre-seed–Seed · Deep tech
Led 2 of 2 rounds tracked in Oxford. Oxford Science Enterprises is an independent investment company and venture builder based…
Ticket undisclosed
view →
Amadeus Capital Partners
Series A–Series B · Deep tech
Led 1 of 1 round tracked in Oxford. Amadeus Capital Partners is a London technology investor founded in 1997 that…
Ticket undisclosed
view →
Apollo Health Ventures
Pre-seed–Seed · Biotech
Led 1 of 1 round tracked in Oxford. Apollo Health Ventures invests in and co-founds early-stage biotechnology companies targeting aging…
Ticket undisclosed
view →